School of Preclinical Medicine | Chengdu University | China
Assoc. Prof. Dr. Mingzhu Song is an accomplished materials scientist and researcher at the School of Preclinical Medicine, Chengdu University, where he has made significant contributions to the fields of nanomedicine, tumor immunotherapy, and advanced drug delivery systems. With a strong academic foundation in Materials Science and Engineering, Dr. Song has served as a senior visiting scholar at Chiang Mai University and Georgia State University, where he collaborated with international teams and expanded his research horizons. His work focuses on the preparation of multifunctional nanomedicine delivery systems, transitioning from single-drug carriers to multifunctional, smart-responsive materials with hierarchical and core–shell structures. By combining structural innovation and active immune dual-targeting surface modifications, his research addresses critical clinical challenges, including poor drug targeting, low therapeutic efficacy, and high recurrence rates in tumor treatment. Dr. Song’s research on anti-tumor immune response represents a paradigm shift, transforming “cold tumors” into “hot tumors,” improving immunotherapy response rates, and establishing long-term anti-tumor immune memory. He leads multiple research projects, including grants from the National Natural Science Foundation of China and the Natural Science Foundation of Sichuan Province, focusing on photodynamic-immunological synergistic therapy and ROS-triggered ferroptosis-based cancer treatments. As a mentor, Dr. Song actively guides postgraduate students in entrepreneurship, bridging academic innovation and real-world application. He currently serves as a youth editorial board member for several international academic journals, including iMeta, Exploration, Food & Medicine Homology, Science of Traditional Chinese Medicine, and Current Pharmaceutical Analysis, where he contributes to shaping the future of scientific publishing. Dr. Song is also a member of the Chinese Society of Biochemistry and Molecular Biology and the Chinese Society for Cell Biology. With over a decade of research experience, multiple Chinese patents, and a growing body of highly cited publications in top-tier journals such as Nano-Micro Letters, Coordination Chemistry Reviews, and Theranostics, Dr. Song has positioned himself as a leading figure in precision tumor immunotherapy research. His interdisciplinary approach integrates materials science, immunology, and oncology, providing a scientific basis for developing next-generation therapies that are safer, more effective, and more personalized. His work not only pushes the boundaries of scientific discovery but also provides practical solutions to some of the most pressing challenges in modern cancer treatment, making him an outstanding candidate for the Best Researcher Award.